Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Furuse

Showing results (121-130 of 348) with videos related to

Pageof 35
Sort By:
Japanese Journal of Clinical Oncology|January 11, 2005
Extrahepatic spread from hepatocellular carcinoma: who are candidates for aggressive anti-cancer treatment?Hiroshi Ishii, Junji Furuse, Taira Kinoshita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Phase II study of radiotherapy employing proton beam for hepatocellular carcinomaMitsuhiko Kawashima, Junji Furuse, Teiji Nishio, et al.
Japanese Journal of Clinical Oncology|November 24, 2005
Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancerJunji Furuse, Hiroshi Ishii, Takuji Okusaka, et al.
Japanese Journal of Clinical Oncology|April 27, 2024
Multicenter validation study of a treatment selection MAP for pancreatic neuroendocrine tumorsMasafumi Ikeda, Susumu Hijioka, Tetsuhide Ito, et al.
Japanese Journal of Clinical Oncology|October 10, 2020
Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trialsSatoshi Nara, Minoru Esaki, Daisuke Ban, et al.
Drugs - Real World Outcomes|January 5, 2023
Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in JapanJunji Furuse, Namiki Izumi, Kenta Motomura, et al.
Anticancer Research|December 6, 2015
Microarray Analysis of Gene Expression at the Tumor Front of Colon CancerTakaaki Kobayashi, Tadahiko Masaki, Eriko Nozaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2011
[Two cases of advanced colorectal cancer which demonstrated the reversibility of oxaliplatin-mediated increase in splenic volume]Shigeatsu Motoori, Takashi Kawase, Hitoshi Nishimura, et al.
Japanese Journal of Clinical Oncology|September 4, 2007
Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcomeAshraf Anas Zytoon, Hiroshi Ishii, Koji Murakami, et al.
Future Oncology (London, England)|February 23, 2025
NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: an open-label, phase II trial designMasafumi Ikeda, Takuji Okusaka, Makoto Ueno, et al.
Pageof 35

Showing results (121-130 of 348) with videos related to

Sort By:
Pageof 35
Japanese Journal of Clinical Oncology|January 11, 2005
Extrahepatic spread from hepatocellular carcinoma: who are candidates for aggressive anti-cancer treatment?Hiroshi Ishii, Junji Furuse, Taira Kinoshita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Phase II study of radiotherapy employing proton beam for hepatocellular carcinomaMitsuhiko Kawashima, Junji Furuse, Teiji Nishio, et al.
Japanese Journal of Clinical Oncology|November 24, 2005
Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancerJunji Furuse, Hiroshi Ishii, Takuji Okusaka, et al.
Japanese Journal of Clinical Oncology|April 27, 2024
Multicenter validation study of a treatment selection MAP for pancreatic neuroendocrine tumorsMasafumi Ikeda, Susumu Hijioka, Tetsuhide Ito, et al.
Japanese Journal of Clinical Oncology|October 10, 2020
Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trialsSatoshi Nara, Minoru Esaki, Daisuke Ban, et al.
Drugs - Real World Outcomes|January 5, 2023
Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in JapanJunji Furuse, Namiki Izumi, Kenta Motomura, et al.
Anticancer Research|December 6, 2015
Microarray Analysis of Gene Expression at the Tumor Front of Colon CancerTakaaki Kobayashi, Tadahiko Masaki, Eriko Nozaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2011
[Two cases of advanced colorectal cancer which demonstrated the reversibility of oxaliplatin-mediated increase in splenic volume]Shigeatsu Motoori, Takashi Kawase, Hitoshi Nishimura, et al.
Japanese Journal of Clinical Oncology|September 4, 2007
Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcomeAshraf Anas Zytoon, Hiroshi Ishii, Koji Murakami, et al.
Future Oncology (London, England)|February 23, 2025
NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: an open-label, phase II trial designMasafumi Ikeda, Takuji Okusaka, Makoto Ueno, et al.
Pageof 35